MedTrace Logo

Creative Drama and Conscious Technology Use in Nursing Students

NCT07454928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2026-03-06

No results posted yet for this study

Summary

Background:

Technology addiction is increasingly recognized as a behavioral addiction that may negatively affect young adults' academic performance, psychosocial well-being, and quality of life. Innovative and evidence-informed educational approaches are needed in nursing education to promote balanced and conscious technology use.

Objective:

This study aims to evaluate the effect of a Creative Drama workshop on nursing students' awareness of technology addiction.

Design:

The study utilizes an embedded mixed-methods design.

Setting:

The study is conducted with nursing students enrolled at a university in Turkey.

Participants:

A total of 110 nursing students participate in the quantitative phase of the study. Twelve nursing students, selected using criterion sampling, participate in the qualitative phase.

Methods:

Quantitative data are collected using the Technology Addiction Scale and analyzed using SPSS. Qualitative data are obtained through field notes and semi-structured interviews and analyzed using thematic analysis with MAXQDA software.

Conditions

  • Creative Drama
  • Nursing Education
  • Technology Addiction

Interventions

OTHER

Creative Drama

A structured Creative Drama workshop conducted to enhance students' awareness of technology addiction through participatory and experiential activities.

Sponsors & Collaborators

  • Erzurum Technical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2024-03-30
Completion
2024-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07454928 on ClinicalTrials.gov